Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis

Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis

Abstract Background//Objective Diabetes affects millions of people globally, despite treatment options, adherence and other factors pose obstacles. Once-weekly Insulin Icodec, a novel basal Insulin analog with a week-long half-life, offers potential benefits, enhancing convenience, adherence, and qu...

Full description

Bibliographic Details
Main Authors: Syed Zia Saleem, Areeba Fareed, Syed Muhammad Muneeb Akhtar, Solay Farhat, Amira Mohamed Taha, Aymar Akilimali
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Insulin Icodec
Insulin Glargine U-100
Type 2 diabetes (T2D)
Once-weekly Insulin regimen
Glycemic control
Online Access:https://doi.org/10.1186/s13098-024-01305-z

Internet

https://doi.org/10.1186/s13098-024-01305-z

Similar Items